Celaid Therapeutics
PrivateLast Round
Series B
Oct 7, 2025
Total Funding Raised
$37.6M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Celaid Therapeutics is a biotechnology company that develops a proprietary platform for the large-scale, ex vivo expansion of human hematopoietic stem cells for use in cell and gene therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Celaid Therapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Celaid Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Oct 7, 2025 | ||||
| Series A Extension | Oct 31, 2024 | ||||
| Grant | Sep 30, 2024 | ||||
| Series A Extension | May 8, 2024 | ||||
| Grant | Mar 22, 2024 | ||||
Series A | Oct 25, 2022 |
Key People
Founding team and executive leadership
Celaid Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Japan Agency for Medical Research and Development | Series B |
| Kobe University Capital | Series A Extension |
| UTEC (The University of Tokyo Edge Capital Partners) | Series B, Series A, Pre Seed, Series A Extension |
| Joyo Capital Partners | Series A Extension, Series B |
| SBI Regional Revitalization Support Corporation | Series A |
| Osaka University Venture Capital Co., Ltd. | Series A, Series B, Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 20, 2025
Selected for the Shonan Health Innovation Conference in Boston.
- Oct 25, 2025
Attending the 2025 AABB/Cord Blood Connect event in San Diego.
Celaid Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Celaid Therapeutics's valuation, stock price, and market status.